Oscar Health (NYSE:OSCR) Trading Up 8.1% – Should You Buy?

Oscar Health, Inc. (NYSE:OSCR)’s stock price traded up 8.1% during mid-day trading on Wednesday . The company traded as high as $30.96 and last traded at $30.8210. Approximately 1,079,339 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 7,758,098 shares. The stock had previously closed at $28.52.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. UBS Group boosted their target price on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Zacks Research downgraded Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. Wolfe Research initiated coverage on Oscar Health in a research note on Tuesday, May 5th. They issued a “peer perform” rating on the stock. Robert W. Baird increased their target price on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health currently has a consensus rating of “Hold” and a consensus target price of $20.78.

Oscar Health Price Performance

The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock’s 50-day moving average price is $24.18 and its 200-day moving average price is $17.77. The company has a market capitalization of $9.67 billion, a price-to-earnings ratio of -54.38, a price-to-earnings-growth ratio of 2.23 and a beta of 2.34.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same quarter last year, the business posted $0.92 earnings per share. Oscar Health’s revenue for the quarter was up 52.6% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Richard Scott Blackley sold 31,683 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $695,125.02. Following the transaction, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at $23,584,995.38. This represents a 2.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the completion of the transaction, the insider owned 259,057 shares in the company, valued at approximately $5,683,710.58. This represents a 4.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 3,662,466 shares of company stock worth $105,145,815. 24.39% of the stock is currently owned by company insiders.

Institutional Trading of Oscar Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Jones Financial Companies Lllp boosted its stake in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the last quarter. Strs Ohio acquired a new stake in shares of Oscar Health during the 1st quarter worth approximately $30,000. Fifth Third Bancorp raised its stake in shares of Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares during the last quarter. Quarry LP raised its stake in shares of Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after buying an additional 1,469 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new position in Oscar Health in the first quarter valued at approximately $49,000. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.